SLT is a cost-effective, first-line glaucoma approach
Dr. Nate Radcliffe shares how Lumenis SLT is a cost-effective first-line approach for patients with glaucoma in this video from ASCRS San Diego.
Nathan M. Radcliffe, MD
Explore Other Resources
Blog PostsPeriorbital Muscle StimulationTreatment TypeVision Resource Hub
Blog PostsPeriorbital Muscle StimulationTreatment TypeVision Resource Hub
No Surgery, No Downtime: How OptiLIFT Transforms Lower Lid Laxity Treatment
NewsPeriorbital Muscle StimulationPress ReleasesTopicTreatment TypeVision Resource Hub
NewsPeriorbital Muscle StimulationPress ReleasesTopicTreatment TypeVision Resource Hub
Lumenis Launches OptiLIFT, a New DMSt Device to Address Lower Lid Laxity and Impaired Blinking.
Blog PostsDry EyeTreatment TypeVision Resource Hub
Blog PostsDry EyeTreatment TypeVision Resource Hub
Interventional Therapy is a Win for Dry Eye Patients
PB-00038930 Rev A